PL254571A1 - Method of obtaining novel isoquinolinic compounds - Google Patents

Method of obtaining novel isoquinolinic compounds

Info

Publication number
PL254571A1
PL254571A1 PL25457185A PL25457185A PL254571A1 PL 254571 A1 PL254571 A1 PL 254571A1 PL 25457185 A PL25457185 A PL 25457185A PL 25457185 A PL25457185 A PL 25457185A PL 254571 A1 PL254571 A1 PL 254571A1
Authority
PL
Poland
Prior art keywords
isoquinolinic
compounds
obtaining novel
image
novel
Prior art date
Application number
PL25457185A
Other versions
PL146066B1 (en
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of PL254571A1 publication Critical patent/PL254571A1/en
Publication of PL146066B1 publication Critical patent/PL146066B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Jib Cranes (AREA)
  • Fats And Perfumes (AREA)
  • Cephalosporin Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Cosmetics (AREA)

Abstract

Neuromuscular blocking agents of formula (1) which are useful as skeletal muscle relaxants during surgery are disclosed. <IMAGE> (1) <IMAGE> and X is an anion, preferably pharmaceutically acceptable.
PL1985254571A 1984-07-18 1985-07-11 Method of obtaining novel isoquinolinic compounds PL146066B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (2)

Publication Number Publication Date
PL254571A1 true PL254571A1 (en) 1986-07-15
PL146066B1 PL146066B1 (en) 1988-12-31

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1985254571A PL146066B1 (en) 1984-07-18 1985-07-11 Method of obtaining novel isoquinolinic compounds

Country Status (30)

Country Link
US (1) US4761418A (en)
EP (1) EP0181055B1 (en)
JP (1) JPH0662568B2 (en)
AT (1) ATE60759T1 (en)
AU (1) AU574481B2 (en)
BG (1) BG60411B2 (en)
CA (1) CA1273341A (en)
CY (1) CY1687A (en)
DD (1) DD235638A5 (en)
DE (2) DE3581699D1 (en)
DK (1) DK168093B1 (en)
ES (1) ES8609260A1 (en)
FI (1) FI85019C (en)
GB (1) GB8418303D0 (en)
GE (1) GEP19960468B (en)
HK (1) HK47593A (en)
HU (1) HU193996B (en)
IE (1) IE58138B1 (en)
IL (1) IL75833A (en)
LT (1) LT2078B (en)
LU (1) LU88801I2 (en)
LV (1) LV5483A3 (en)
MC (1) MC1690A1 (en)
MX (1) MX9203667A (en)
NL (1) NL940023I2 (en)
NZ (1) NZ212766A (en)
PL (1) PL146066B1 (en)
SG (1) SG3493G (en)
SU (1) SU1468414A3 (en)
ZA (1) ZA855407B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
DE69840816D1 (en) * 1997-03-25 2009-06-18 Avera Pharmaceuticals Inc Isoquinolines and their preparation
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
WO2005041960A2 (en) * 2003-10-28 2005-05-12 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
JP5213137B2 (en) * 2006-12-06 2013-06-19 コーネル リサーチ ファウンデーション， インコーポレイテッド Medium duration neuromuscular blockers and antagonists thereof
US8461338B2 (en) * 2007-03-08 2013-06-11 Chemagis Ltd. (1R, 1′R)-atracurium salts separation process
EP2125743A1 (en) * 2007-03-26 2009-12-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
BRPI0809892A2 (en) * 2007-05-01 2014-09-30 Chemagis Ltd ISOQUINOLIN COMPOUND, CRYSTALLINE FORM, CRYSTALLINE COMPOUND (VII) AND METHOD FOR PREPARING CIS-ATTRACURIUM
EP2155684B1 (en) * 2007-05-01 2014-04-09 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357805B2 (en) * 2007-06-18 2013-01-22 Chemagis Ltd. (1R,1′R)-atracurium salts separation process
BRPI0812625A2 (en) * 2007-07-09 2019-02-19 Chemagis Ltd process for preparing a cis-atracurium salt
US8354537B2 (en) * 2007-10-29 2013-01-15 Chemagis Ltd. R,R1-atracurium salts
ITMI20080319A1 (en) 2008-02-28 2009-08-29 Recordati Chem Pharm PROCESS FOR RESOLUTION OF ISOCHINOLINIC DERIVATIVES
US20110185796A1 (en) * 2008-05-01 2011-08-04 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (en) 2009-08-19 2017-03-15 康奈尔大学 Cysteine for physiologic infusion
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
US9156826B2 (en) 2012-06-29 2015-10-13 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (en) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 Preparation method of cis-benzyl isoquinoline compound and application thereof
CN107782821B (en) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 Analysis method of neuromuscular blocking agent
CN107778237A (en) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 A kind of novel crystal forms of neuromuscular blocking agent intermediate and its production and use
CN108938573B (en) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 Neuromuscular blocker composition and preparation method and application thereof
CN108503564A (en) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride
CN110361472B (en) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 HPLC detection method of mikui ammonium chloride intermediate MIV-G isomer
CN111004179B (en) * 2019-11-11 2021-03-09 武汉大安制药有限公司 Resolution method of 5' -methoxylapatin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
FR2399429A1 (en) * 1977-08-01 1979-03-02 Massachusetts Gen Hospital MYORELAXANT TETRAHYDRO-ISOQUINOLEINIC COMPOUNDS (NEUROMUSCULAR PLATE BLOCKING AGENTS) AND MEDICINAL PRODUCT CONTAINING THESE SUBSTANCES
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (en) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
CA1178275A (en) * 1980-12-17 1984-11-20 David A. Yeowell Bis-isoquinolinium salts as long duration neuromuscular blocking agents
JPS5899465A (en) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド Isoquinoline derivative

Also Published As

Publication number Publication date
DD235638A5 (en) 1986-05-14
SG3493G (en) 1993-03-12
US4761418A (en) 1988-08-02
HUT40626A (en) 1987-01-28
DK168093B1 (en) 1994-02-07
AU4510885A (en) 1986-01-23
NZ212766A (en) 1988-03-30
FI85019C (en) 1992-02-25
LV5483A3 (en) 1994-03-10
JPH0662568B2 (en) 1994-08-17
LU88801I2 (en) 1996-11-05
GB8418303D0 (en) 1984-08-22
GEP19960468B (en) 1996-08-29
IL75833A0 (en) 1985-11-29
NL940023I1 (en) 1995-01-02
LT2078B (en) 1993-06-15
FI852807L (en) 1986-01-19
ES8609260A1 (en) 1986-09-01
IE58138B1 (en) 1993-07-14
DK324985A (en) 1986-01-19
FI852807A0 (en) 1985-07-17
HK47593A (en) 1993-05-21
AU574481B2 (en) 1988-07-07
EP0181055B1 (en) 1991-02-06
DK324985D0 (en) 1985-07-17
HU193996B (en) 1987-12-28
PL146066B1 (en) 1988-12-31
DE3581699D1 (en) 1991-03-14
JPS6187666A (en) 1986-05-06
NL940023I2 (en) 1998-06-02
MX9203667A (en) 1992-07-31
SU1468414A3 (en) 1989-03-23
CA1273341A (en) 1990-08-28
FI85019B (en) 1991-11-15
ATE60759T1 (en) 1991-02-15
ZA855407B (en) 1986-04-30
MC1690A1 (en) 1986-07-18
BG60411B2 (en) 1995-02-28
CY1687A (en) 1993-10-10
DE19675039I2 (en) 2003-01-09
IE851791L (en) 1986-01-18
ES545319A0 (en) 1986-09-01
IL75833A (en) 1988-11-30
EP0181055A1 (en) 1986-05-14

Similar Documents

Publication Publication Date Title
PL254571A1 (en) Method of obtaining novel isoquinolinic compounds
ZA857270B (en) Tetralin derivatives,their preparation and their use
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
IE831113L (en) 7-oxabicyclo £2,2,1| heptane derivatives
IL72354A0 (en) Imidazolium salts,processes for the preparation thereof and pharmaceutical compositions containing the same
EA199900756A1 (en) SUBSTITUTED ISOHENOLINS AS NERVOUS-MUSCLE BLOCKS OF ULTRASTRICATED ACTION
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
AR242561A1 (en) Procedure for the preparation of s-(-)-1-propyl-2&#39;,6&#39;-pipecoloxylidide hydrochloride that is substantially pure, and the procedure involved.
IL79910A0 (en) Tricyclic compounds,process for the preparation thereof and pharmaceutical compositions containing the same
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
DE3173866D1 (en) Compounds and compositions for treatment of ocular hypertension
IL82317A0 (en) 1,4 dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
ES2027507A6 (en) Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
YU134489A (en) Process for preparing vapours of enanthiomers (ar,1&#39;s)(as,1&#39;r)-3-/n-(metoxyacethyl)-n-(3-chlorine-2,6-diethylphenyl)/-amino-tetrahydro-2-furanone
ZA814195B (en) Compounds and compositions for treatment of ocular hypertension
PH12015A (en) Method and composition for the treatment of athlete&#39;s foo